Ethics

Management that places corporate ethical compliance with an assertive attitude as the code of conduct

2023: 1st ex-post audit on ISO 27001 (information security)/ISO 27701 (personal information protection) international standard certifications; 1st ex-post audit on ISO 37001 (anti-bribery management system) international standard certification (after certification renewal)

2022: Officers and employees company-wide sign the anti-corruption and fair competition pledge (1,907 officers and employees); General and intensive fair-competition training for new transferees of the sales and marketing department for the first half of the year (26 employees); CP/anti-competition training for interns (16 interns); Became the first company to simultaneously obtain ISO27001(information security) and ISO27701(personal information protection) certifications; Signed the 2022 Korean Association for Industrial Technology Security Project for Enhancement of Security at Mid-Size Enterprises and received government subsidies; Conducted due diligence on product information sessions and symposia where lodging is provided; 5th advanced development phase for the economic benefit and expenditures reporting system (process automation and improved monitoring efficiency); General and intensive fair-competition training for new transferees of the sales and marketing department for the second half of the year; Received a regular CP audit for LG Life Sciences partners; Received a regular CP audit for AstraZeneca Korea partners; Regular update of the 2022 company-wide corruption risk assessment report; Conducted 2022 internal audit on anti-corruption management (random selection of 36 teams from headquarters, research center, and factories); 2022 Anti-corruption CEO management review report; Anti-corruption training for all employees (1,847 persons)

2021: 24th amendment to CP SOP; Conducted anti-corruption and CP training for all employees for 2021; Conducted training and instruction of marketing department personnel on rebate prevention and fair competition (completed by 413 employees); Provided general and intensive instructions on fair competition for newly transferred members of the sales and marketing department (completed by 20 employees); ISO37001 certification renewed; Continuing education and renewal of certification for certified compliance professionals (CCPs) (current number of certified professionals: 7 Class I professionals, 1 Class II professional); ISO37001 examiner certification acquired (2 employees); Expanded communication channels on compliance regulations and laws (FAQ notice and internal inquiry boards); 11th CP committee (a total of 62 new sales and marketing plans reviewed, 9 sent back); Exhaustive review of sales and marketing budget expenditures; Three instances of on-site due diligence on product information sessions where invitees were provided lodging

2020: Made the 23rd revision for CP SOP; Strengthened CP monitoring for co-promotion product marketing activities; Advanced the economic interest expense report system (3rd time); Tightened standards for product presentations targeting health professionals; Created online CP Q&A/FAQ bulletin boards; 2020: Attended KPBMA ethical management academy/workshop; 2020: Company-wide anti-corruption training; 2020: Sales/marketing CP training; ISO 37001 ex-post audit (3rd year); Added 1 CCP-certified person

2019: Conducted follow-up review for ISO 37001 (2nd year); Advanced the economic interest expense report system (2nd time); Invited an outside expert to provide compliance training to employees; Published CP Handbook 5th Edition (Supplementary); Ensured that all CP staff had CCP Level 1 qualification; Reinforced the CP operating process

2018: Obtained ISO 37001 certification of anti-bribery management
※ International anti-bribery management system; Developed an economic interest expense report system; Published CP Handbook 5th Edition; Ensured that 3 employees newly acquired Certified Compliance Professional (CCP) Level 1

2017: Received AA rating in CP rating 2 consecutive times
(first in the pharmaceutical industry); Send CP letters to all management and employees twice a month
(send relevant laws/regulations and issues); Constructed ‘economic profit expenditure report’ system

2016: Pre-post inspection for constructing a CP monitoring CES system; Publish CP FAQ guidebook; Newly establish the Daewoong Pharmaceutical ‘webzine’ compliance board; CP work organization → Legal team/CP team operated separately

2015: Received AA rating in CP ratings
(first in the pharmaceutical industry, highest rating); Awarded ‘Presidential Medal’ on Fair Trade Day for autonomous compliance manager; Published 4th CP handbook; Foster holders of grade 1 compliance management experts; Operate legal CP team (appointed legal advisor attorney)

2014: Published third CP handbook; Newly organized CP team directly under the CEO; In-company cyber classroom; Newly established fair trade training course
(8 classes, supported by the company); Published ethical management handbook

2011: Published second CP handbook; Enacted integrated CP regulations for Daewoong Group

2008 Compliance Program history: Published the first CP handbook in the pharmaceutical industry

2007: Introduced fair trade autonomous compliance program; Established compliance organization